Pharmacologically active isolated or purified dauer...

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S460000

Reexamination Certificate

active

07119213

ABSTRACT:
The present invention discloses a method for effectively isolating and purifying a physiological active dauer pheromone compound having the following structural formula I related to aging and stress ofC. elegans, and determination of the structure of such material. First, ethanol extract is prepared by completely concentrating a liquid medium with ethanol after culturingC. eleganson a S. basal liquid medium, and then this ethanol fraction is further extracted with ethyl acetate. Then, impurities are removed from ethyl acetate extract by a silica-gel adsorption chromatography and a pheromone extract is isolated and purified by amine column chromatographic procedures using various solvents as eluent. Finally, a pheromone compound having structural formula I is completely isolated and characterized by size-exclusion HPLC.

REFERENCES:
Chem. Abs vol. 134 No. 160429(2000).
Chem. Abs. vol. 132 No. 163700(2000).
Chem. Abs. vol. 127 No. 642760(1997).
Curran Angew. Chem. Int. Ed. vol. 37 pp. 1175-1190, 1194-1196(1998).
Pan-Young Jeong, et al; “Chemical structure and biological activity of theCaenorhabditis elegansdauer-inducing pheromone”; letters to nature, vol. 433, Feb. 3, 2005, Nature Publishing Group; pp. 541-545.
Golden, James W., et al; “A pheromone-induced developmental switch inCaenorhabdits elegans: temperature-sensitive mutants reveal a wild-type temperature-dependent process”; Proc. Natl. Acad. Sci., United States of America, vol. 81, Feb. 1984, pp. 819-923.
Ogg, Scott, et al; “The fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C.elegans”; Nature, vol. 389, Oct. 30, 1997; pp. 994-999.
Golden, James W. et al; “A pheromone influences larval development in the nematodeCaenorhabditis elegans”; Science, vol. 218, Nov. 5, 1982; pp. 578-580.
Tissenbaum, Heidi A., et al; “A common muscarinic pathway for diapause recovery in the distantly related nematode speciesCaenorhabditis elegansandAncylostoma caninum”; PNAS, vol. 97, No. 1, Jan. 4, 2000; pp. 460-465.
Vowels, Jennifer J. et al; “Multiple chemosensory defects indaƒ-11 anddaƒ-21 mutants ofCaenorhabditis elegans”; Genetics 138, Oct. 1994, pp. 303-316.
Zwaal, Richard R.; “Two neuronal G proteins are involved in chemosensation of theCaenorhabditis elegansdauer-inducing pheromone”; Genetics 145; Mar. 1997, pp. 715-727.
Inoue, Takao et al.; “Suppressors of transforming growth factor-β pathway mutants in th eCaenorhabditis elegansdauer formation pathway”; Genetics 156; Nov. 2000; pp. 1035-1046.
Ailion, Michael et al; “Dauer formation induced by high temperatures inCaenorhabditis elegans”; Genetics 156; Nov. 2000; pp. 1047-1067.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pharmacologically active isolated or purified dauer... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmacologically active isolated or purified dauer..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmacologically active isolated or purified dauer... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3670600

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.